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Abstract
The quality of gene expression microarray data has improved dramatically since the first arrays were introduced in the late
1990s. However, the reproducibility of data generated at multiple laboratory sites remains a matter of concern, especially for
scientists who are attempting to combine and analyze data from public repositories. We have carried out a study in which a
common set of RNA samples was assayed five times in four different laboratories using Affymetrix GeneChip arrays. We
observed dramatic differences in the results across laboratories and identified batch effects in array processing as one of the
primary causes for these differences. When batch processing of samples is confounded with experimental factors of interest
it is not possible to separate their effects, and lists of differentially expressed genes may include many artifacts. This study
demonstrates the substantial impact of sample processing on microarray analysis results and underscores the need for
randomization in the laboratory as a means to avoid confounding of biological factors with procedural effects.
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Introduction
The gene expression microarray has become a ubiquitous tool in
modern biology resulting in substantial accumulation of data in
public repositories [1]. Researchers now routinely combine or
compare results from different studies. This practice raises concerns
about the reliability and reproducibility of microarray data that have
been generated across multiple laboratories. Several studies have
been conducted to compare performance across different gene
expression platforms and laboratories [2–5]. These studies have
generally concluded that, although absolute expression levels may
differ, there is a substantial concordance of results obtained. While
these findings provide confidence in microarray technology, it is
important to be aware that this positive message was based on
comparisonsofthebest-performinglaboratories[2]oronsmallsetsof
top ranked genes [3]. As we demonstrate here, there is still cause for
healthy skepticism regarding the reproducibility of microarray data.
Studies of the reproducibility of microarray data can vary in
scope. Most studies use a common set of samples, but the
embedded biological signals can be small or large, and they may or
may not include truth standards such as ‘spike in’ RNA or
mixtures of RNAs from knockout cell lines [2]. One could look at
performance across different platforms, across different laborato-
ries or apply different methods of analysis. We chose to look at the
effect of processing samples at different laboratory sites. We
employed a common array platform, the Affymetrix GeneChip
Mouse 430v2, and used a common set of 16 RNA samples with
moderate expression differences.
We collected kidney tissue samples from two male and two female
mice from the C57BL/6J strain and from each of three chromosome
substitution strains (CSSs) [6], C57BL/6J-Chr1
A/J, C57BL/6J-
Chr6
A/J and C57BL/6J-Chr15
A/J. We will denote these strains as
B, A1, A6, and A15 in this paper. Sample were distributed to each of
four centers, and one center processed two sets of the 16 samples at
different times using different labeling protocols. For simplicity we
refer to these as five centers (C1–C5). We selected these strains based
on the expectation that differentially expressed genes between the
background strain B and each of the CSSs would be enriched for
genes on the substituted chromosome. However there are no truth
standards so our results reflect the precision but not necessarily the
accuracy of the platform. Samples were delivered to each of the sites
with the suggestion that they be processed according to standard
protocols in a manner typical for that laboratory. Data from each
center were provided in the form of CEL files.
To investigate variability among centers, we applied a typical
collection of interpretive analysis tools to data from each laboratory
and made quantitative comparisons of the results. These analysis
tools address the objective of generating and comparing lists of
differentially expressed genes, identifying enriched biological
pathways that are in common or differ between experiments,
clustering the samples by expression pattern, and classifying new
samples [7–10] using accumulated data.
PLoS ONE | www.plosone.org 1 November 2008 | Volume 3 | Issue 11 | e3724The efforts of user groups such as The Microarray and Gene
Expression Data (MGED) society [1] have enabled the sharing of
both primary and procedural data from microarray studies. The
value of these resources depends in part on the availability of
detailed description of the platforms and procedures used to
generate the data. In this study we demonstrate that dramatically
different results can be obtained when the same samples are
processed in different laboratories. We identify and discuss the
procedural origins of some of these differences. This illustrates
both the importance and the limitation of current experimental
annotation standards.
Results
Normalized intensity profiles
We normalized data from each center separately using the
Robust Multichip Average method (RMA) [11]. The distribution
of normalized intensities is an important diagnostic of microarray
data quality. RMA processed intensities can be plotted as
smoothed histograms as in Figure 1a. The distributions vary
dramatically across centers. Centers 2 has the highest median
intensity. This was not unexpected because center 2 used the
original Affymetrix array labeling protocol incorporating two
labeled NTPs (biotin UTP and biotin CTP), and all other centers
used a newer labeling protocol that incorporates one NTP (biotin
UTP). However, the low intensity of data from centers 4 and 5 is
notable. Distributions for centers 1 and 3 show median intensities
in the expected range.
Microarray analysis is typically focused on changes in
expression level across conditions. Thus differences in intensity
between samples are often more important than absolute intensity
levels. The median absolute deviation (MAD) across 16 arrays
within each center (Figure 1b) show that centers 4 and 5 have the
highest internal variation and center 2 has the lowest.
As an aside, we normalized the entire set of 80 arrays from all
centers together. This reduced the overall intensity differences but
created an even greater difference in MAD distributions between
centers 4 and 5 compared to the other centers. From the outset of
our analysis we can see that there are differences in the distribution
of intensity across centers that cannot be removed by normaliza-
tion procedures. All results described below are based on RMA
normalization of data from each center separately.
Differential expression
Our experiment includes two biological factors of interest, strain
and sex. We constructed statistical tests for the effects of these
factors using a linear model that included both factors as main
effects with no interaction. Thus tests for strain differences are
Figure 1. Intensity across centers. Median intensity (a) and Median absolute deviation across centers (b). Samples from each center are
individually RMA processed.
doi:10.1371/journal.pone.0003724.g001
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test for overall differences as well as each of the pairwise contrasts.
Other models and comparisons could be considered but we found
these to be sufficient for illustrating the differences among centers.
We determined the numbers of genes having significant strain or
sex effects using p-value, q-value, and fold-change criteria
(Table 1; Figure 2). There are striking differences in the
numbers of differentially expressed genes across centers. For
overall strain effects, the numbers of differentially expressed genes
from centers 4 and 5 can be as much as five times that of other
centers. The same trend is seen for the pairwise strain comparisons
with two exceptions; the comparisons of B versus A1 within center
5, and the comparison of A6 versus A15 in center 4 are
comparable to the results from centers 1, 2, and 3. Conversely, for
sex effects, centers 2 and 3 have the longest lists. In all cases, these
differences are the most pronounced when using the q-value
criteria and least when fold-change criteria are used.
To further investigate the effects of the multiple test adjustment
on differential gene lists, we looked at the estimated proportions of
non-differential genes (^ p p0), and the false discovery rate [12–13]
corresponding to fixed p-value thresholds for overall strain and sex
effects (Table 2). Centers 4 and 5 have much higher estimated
proportions of differentially expressed genes (lower ^ p p0) than the
other centers. For the sex effect, centers 2 and 3 have somewhat
higher estimated proportions of differentially expressed genes.
When ^ p p0 is lower, the q-value corresponding to a fixed p-value is
lower. Thus the q-value criteria will tend to exaggerate differences
in the list lengths as we have observed.
The numbers of DE genes found in common among pairs of
centers and among all centers using q-value,0.05 is shown in
Table 3. Center 4 and 5 have more DE genes and thus share a
greater number of DE genes but the proportion of shared genes is
only about 17%. On the other hand, centers 1, 2, and 3 have fewer
DE genes, and fewer DE genes in common among pairs of centers,
but the proportions are higher at about 50%. For the sex effect,
centers 2 and 3 share the most common DE genes since both have
many DE genes and have proportion in common at about 54%.
For the other centers the proportion of common genes is at about
50%, indicating greater consistency across centers for sex effect
than for strain effect.
To understand the nature of different number of DE genes across
center, we studied them by chromosome. Since samples were
obtained from chromosome substitution strains, we expected to see
enrichment of DE genes on the substituted chromosomes. From the
overall and strain pairwise comparisons tests, we selected DE genes
by q-value,0.05 and obtained the proportion of significance gene
by chromosomes (Figure 3). As we expected, higher number of DE
genes were found at chromosomes 1, 6, and 15. Center 4 and 5
show the same pattern, except the number of DE genes are higher
than other centers across all chromosomes. Pairwise strain
comparison show B and A6, and B and A15 strain comparisons
have higher number of DE genes in chromosome 6 and 15,
respectively, as we expected. However, center 4 and 5 show notably
higher number of DE genes in B and A6, and A15 and A1 or A6
comparison, respectively, and we will discuss this later.
To avoid the problem of comparing lists of very different
lengths, we considered genes in rank order by the size of the Fs test
statistic or equivalently by p-value. If the rank order of genes is
preserved, we might conclude that results are consistent across
centers but that p-values are poorly calibrated. We selected lists of
various fixed lengths based on rank ordering and calculated the
proportion of genes found in common across centers. This type of
analysis has been referred to as corresponding at the top (CAT) by
Irizarray et al. [2] In general, the proportion of genes in common
across centers initially increases and then slowly decreases as the
list length is increased (Figure 4). For the overall strain
comparison, the CAT plots peak at a list length of about 70
genes with 60% to 80% pairwise correspondence, and overall
correspondence of about 50% in common across all centers. For
Table 1. Numbers of DE genes having significant sex and
strain effects at various p-value, q-value, and fold-change
thresholds.
Threshold C1 C2 C3 C4 C5
Strain effect
Overall 0.001 377 462 517 1390 1290
p-value 0.01 939 1160 1200 4907 4522
0.05 2732 3296 3119 10943 10618
Overall 0.001 116 134 170 0 184
q-value 0.05 188 219 265 571 819
0.01 285 376 423 6362 5361
1 135 103 118 216 532
Fold-change 1.5 56 44 52 69 124
2 2 92 33 53 45 7
3 76881 0
Pairwise strain effect
B vs.A1 0.001 223 252 270 458 295
p-value 0.01 648 911 814 2124 989
0.05 2202 3002 2507 6185 3540
B vs.A6 0.001 119 190 198 1206 417
p-value 0.01 400 703 704 4771 1963
0.05 1699 2498 2667 10889 6121
B vs.A15 0.001 150 133 123 821 616
p-value 0.01 714 460 542 3068 2765
0.05 3067 2224 2302 7368 6962
A1 vs.A6 0.001 323 367 463 820 605
p-value 0.01 815 826 1086 2600 2407
0.05 2591 2129 3005 6390 6883
A1 vs.A15 0.001 284 301 372 1180 1005
p-value 0.01 873 986 927 3424 3728
0.05 3067 3490 2794 7495 8361
A1 vs.A15 0.001 209 287 254 313 1053
p-value 0.01 641 919 783 1531 4286
0.05 2377 3344 2552 5493 10188
Sex effect
0.001 3250 5099 5842 4003 3663
p-value 0.01 6327 10721 10959 7357 7221
0.05 10691 18039 17445 12439 12054
0.001 1452 3149 4078 2292 1568
q-value 0.01 3287 8766 9141 4697 4146
0.05 6360 18910 17475 8872 8071
1 313 277 320 347 368
Fold-change 1.5 139 126 139 167 145
2 8 67 08 91 1 0 8 8
3 3 53 13 65 44 0
Fold-change is based on the log2 transformation.
doi:10.1371/journal.pone.0003724.t001
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PLoS ONE | www.plosone.org 3 November 2008 | Volume 3 | Issue 11 | e3724Figure 2. Number of differentially expressed (DE) genes having strain (a, b and c) and sex effect (d, e and f). Number of DE genes
selected by p-value (a and b), focusing on up to p-value,0.001 (c and d) and q-value (e and f). Center 4 and 5 have higher number of DE genes when
strain effect was tested. However, Center 4 has smaller number of genes than other centers until p-value,2e-04 (panel c), then the number of gets
increased, and that causes sudden increase in q-value (panel e). When sex effect is tested, center 2 and 3 show higher number of DE genes than other
centers, however the difference is not as big as that of strain effect.
doi:10.1371/journal.pone.0003724.g002
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comparisons. Best peak correspondence is achieved at list lengths
of 500 and, this high level of correspondence at 50% to 70%
persists for very long lists.
Strong concordance based on rank order indicates that many of
the centers are picking the same genes and suggests that
calibration of p-values and q-values is contributing to the
difference in list lengths. It does not guarantee that the lists are
biological in origin. If we had data from only one center, it would
be difficult to detect these problems or to determine how many
genes are truly differentially expressed.
Functional analysis
Gene lists established by statistical criteria may vary across
centers, but it is possible that they will still support the same
biological functions. To test this idea, we selected differentially
expressed genes for overall strain and sex effect at q-value,0.05
and identified significant GO terms [14] enriched in the selected
genes using Hypergeometric test [15] at p-value,0.01. The
numbers of significant GO terms supported by the strain effects
lists are much longer for centers 4 and 5 compared to the other
centers. There is limited pairwise overlap among the centers and
only a single GO term (GO:0048276, the process of gastrulation)
in common among all five (Table 3). For the sex effects, there are
about 50 significant GO terms for each center, and overlap is the
best among centers 1, 4 and 5. Two GO terms (GO:0019752,
carboxylic acid metabolic process; GO:0006631, fatty acid
metabolic process) were found among all five centers.
Principle components
Another way to assess the similarity among centers is to identify
common features in the major patterns of variation. We applied
principal component analysis (PCA) to data from each of the five
centers and plot the first vs. second (Figure 5) principal components.
The first principal component from each center corresponds to the
sex effect; it separates male vs. female samples. The second principal
component is different for each center. For most centers the second
principal component tends to separate strain effects but not in a
consistent manner across centers. For instance, second principal
components from centers 1 and 3 separate A1 from A6 (or A1 from
other centers) but center 5 groups these strains together.
Classification of samples
In this section we address the problem of combining data across
centers for the purpose of classification of samples. We used
nonnegative matrix factorization (NMF) method, more specifically
the metagene projection procedure as proposed by Tamayo et al. [9].
First we computed a hierarchical clustering of samples using the
original data for all centers together (Figure 6a). The data is first
clustered perfectly by center. Within centers, there is also perfect
clustering by sex, and there is a reasonably good pairing of samples
of the same strain within sexes. This reflects the relative magnitude
of signals as we observed with the PCA.
Next, following Tamayo et al. [9], we chose one center as a
training set, computed the expression profile of the metagene and
weight matrices, and projected the corresponding metagene
profiles onto the other four data sets. Clustering of the metagenes
obtained using center 3 as the training set (Figure 6b) first
separates the A1 strain from the other strains. Within A1 it
separates sex, and within the other strains it separates sex first then
separates strains. Male samples from strains B and A6 are mixed,
but in general the separation according to the strain and sex is
reasonable. However when center 4 was used as a training set,
there is no consistent pattern in the clusters (Figure 6c). Clusters
derived by training on each of the other centers vary in quality
between these two extremes (Supplementary Figure S1).
This illustrates the risks of combing data or classifying samples
using existing data. Although in one case (training on center 3) we
were able to extract a biological signal from the combined data, in
practice it may be difficult to know when the projection method is
effective.
Batch effects
We demonstrated that lists of differentially expressed genes vary
across centers. Here we consider a possible explanation for those
Table 2. The estimated proportion of non DE genes (^ p p0), and
q-values corresponding to fixed p-values for each center.
C1 C2 C3 C4 C5
Strain ^ p p0 0.96 0.95 0.99 0.42 0.43
p-value q-value
0.001 0.12 0.09 0.09 0.01 0.02
0.01 0.46 0.37 0.38 0.04 0.04
0.05 0.80 0.65 0.72 0.09 0.09
Sex ^ p p0 0.70 0.36 0.39 0.53 0.62
p-value q-value
0.001 0.01 0.00 0.00 0.01 0.01
0.01 0.05 0.01 0.02 0.03 0.03
0.05 0.16 0.04 0.05 0.10 0.12
doi:10.1371/journal.pone.0003724.t002
Table 3. Number of significant DE genes selected at q-
value,0.05, and GO terms enriched in DE genes using
Hypergeometric test at p-value,0.01.
Strain Sex
Num.of
Genes
Num.of GO
terms
Num.of
Genes
Num.of GO
terms
C1 285 14 6360 56
C2 376 11 18910 53
C3 426 16 17475 49
C4 6362 50 8872 48
C5 5361 47 8971 55
C1&C2 213 3 5516 10
C1&C3 229 5 5659 14
C1&C4 251 2 4808 22
C1&C5 257 1 4896 27
C2&C3 277 6 12715 14
C2&C4 320 3 7583 13
C2&C5 328 2 6803 6
C3&C4 357 6 7655 17
C3&C5 359 2 6900 14
C4&C5 1672 13 5526 24
All 182 1 4044 2
doi:10.1371/journal.pone.0003724.t003
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PLoS ONE | www.plosone.org 5 November 2008 | Volume 3 | Issue 11 | e3724Figure 3. Number of significantly differentially expressed (DE) genes in each chromosome selected by q-value,0.05. Panel a shows
the DE genes from the overall test, and Panel b to f show the DE genes from the pairwise strain comparisons from each center. Center 4 and 5 have
higher number of DE genes across all chromosomes. Panel e and f show higher number of DE genes in center 4 (B vs. A16) and center 5 (A15 vs. A1 or
A6).
doi:10.1371/journal.pone.0003724.g003
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(Figure 1) within each center suggest the differences were generated
while the samples were being processed. A retrospective analysis of
the laboratory steps used to process the samples revealed that samples
were processed together in batches in a manner that reflects some of
the differences that we observed. Affymetrix GeneChip arrays are
processed in four steps: labeling, hybridization, wash and staining,
and scanning. We identified samples that were processed together in
each of these steps in each of the cent e r sa n di d e n t i f i e db a t c he f f e c t s
that help to explain some of the differences that we observed between
centers. Due to personnel and equipment constraints, allsamples may
not be processed at one time. For instance, one fluidics station used
for the wash and staining step, is able to process only up to four
samples. The numbers of array that can be hybridized together is
constrained along with several other steps in sample processing. Each
center resolved these limitations in different ways, and some of these
are problematic.
Center4hybridizedsamplesintwodays;eightsamplesfromBand
A1 on the first day and another eight samples from A6 and A15 on
the second day. Center 5 hybridized samples over three days; B and
A1 on the first, A6 on the second, and A15 on the third day
(Supplementary Table S1). This is consistent with the long lists of
differential expressed genes among strain for these two centers. For
c e n t e r4 ,t h ep a i r w i s ec o m p a r i s o n sb e t w e e ns t r a i n sBa n dA 1a n d
between A6 and A15 produced relatively short lists (Table 1). For
center 5, the B versus A1 comparison is similar to centers 1, 2, and 3
(Table 1).
Both centers 2 and 3 stored male arrays at 4 degrees while
female samples were washed and stained. These centers have the
longest lists of differentially expressed genes between sexes
(Figure 2). The effect is less than that for the strain comparisons
between centers 4 and 5, which may indicate that the batch effects
of wash and staining are less dramatic or may it reflect the strength
of signal in the sex effect, or both.
Unlike other centers, center 1 randomized the samples before
processing. Arrays were hybridized in two batches, one of 12
samples and another with four samples, on the same day. Due to
chance in the randomization, the smaller batch included 3 male
samples resulting in partial confounding of batch with sex. In all
comparisons center 1 has consistently has the shortest list of
differentially expressed genes (Table 1).
In all cases where processed batches correspond to a biologically
interesting feature of the data, we see an increase in the number of
apparently differentially expressed genes. For any one center it is
not possible to distinguish the effect of batch processing from the
biological effect. The magnitude of the batch effect can be
significant or negligible, but it cannot be removed from the data
without compromising the biological signal.
Figure 4. DE genes are selected by rank of Fs test statistics. The proportion of genes shared by centers when strain (a) and sex (b) being
tested.
doi:10.1371/journal.pone.0003724.g004
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We have described laboratory to laboratory variation in
microarray data that can be attributed to effects of processing
samples in batches. The same RNA samples were processed
independently five times in four different laboratories using the
same Affymetrix GeneChip platform. In centers 2 and 3, female
and male samples were processed separately at the washing step,
and in centers 4 and 5, samples were hybridized together in groups
defined by strain. In all cases, the gene lists corresponding to the
confounded factors were substantially longer than gene lists
obtained from the other centers where the same confounding
Figure 5. Principal component analysis is applied to data from each center, and first and second principal components are plotted.
doi:10.1371/journal.pone.0003724.g005
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confounding factors, this kind of detailed information about
sample processing is not typically available in publicly archived
microarray data. Methods to correct for batch effects have been
proposed [16,17] and their benefits have been demonstrated.
However when a batch effect is confounded with an experimental
factor, correcting for the batch will also effectively remove the
biological signal. It is a common practice to organize samples
having similar characteristics in groups that are processed
together. We strongly recommend against this practice. It is
important to identify all potential batch effects in a sample
processing pipeline and to assign samples to batches using a
randomization mechanism.
With the benefit of hindsight, we might have recommended that
in this experiment the samples be processed in each laboratory as
follows. The samples should be hybridized in two batches of eight.
Each batch should consist of a randomly chosen sample from each
of the eight sex-strain pairs. Within each batch the wash and
staining should be done on randomly selected sets of four samples,
or with random selections balanced across sexes. In addition to
avoiding confounding, this strategy has the added benefit that
batch can be included as a random effect term in the per-gene
ANOVA model to reduce error variation and thus increase power
of the design.
We do not intend to convey a message that the microarray data
are not reliable. Instead, we wish to highlight the importance of
randomization in all laboratory procedures. Careful attention to
the potential for confounding effects of these procedures will
improve the quality of microarray data and the reliability of
analysis results. The effects we observed here primarily impact the
length of differentially expressed gene lists, and these are
exacerbated by the application of FDR correction [13]. The
Figure 6. Sample clustering of original data (a). Using center 3 and center 4 as training set, get the H matrix (containing expression level of
metagene from each sample), project the metagene to each center and cluster the projected data (b and c respectively).
doi:10.1371/journal.pone.0003724.g006
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groups, but the perturbations that causes these differences
represent a mixture of biological and technical effects. In a
randomized experiment, technical variation will be balanced
across treatment groups, and differentially expressed gene lists will
more accurately reflect the biological differences between samples.
The laboratories involved in this study have updated their
practices to incorporate randomized assignment of samples to
processing batches. This can be a challenging problem that
requires careful coordination of samples to achieve efficient
throughput without compromising data integrity.
Materials and Methods
RNA Samples
Kidney tissue samples were collected from two male and two
female mice from the C57BL/6J strain and from each of three
chromosome substitution strains (CSSs), C57BL/6J-Chr1
A/J,
C57BL/6J-Chr6
A/J and C57BL/6J-Chr15
A/J. In these CSSs,
one chromosome derived from the inbred strain A/J has been
crossed onto the C57BL/6J background [6]. A total of 16 RNA
samples were prepared as described previously [18]. The Animal
Care and Use Committee at The Jackson Laboratory reviewed
and approved all animal procedures.
Target labeling and hybridization
All centers used the one-cycle cDNA synthesis/in vitro-
transcription (IVT) method recommended by Affymetrix to
amplify and label cRNA targets for array hybridization (Affyme-
trix GeneChip Expression Analysis Technical Manual). Centers 1,
3, 4, and 5 used the IVT reagent kit supplied by Affymetrix while
center 2 used the IVT kit supplied by ENZO. Target
fragmentation, array hybridization and post-hybridization array
processing were performed as per manufacturer’s recommenda-
tions. However, specific implementation of labeling, hybridization
and array processing protocols were according to routine
procedures in operation in each center. Several differences in
protocol implementation among centers were noted. These
include: 1) amount of hybridization solution applied to each
array; 2) rotation per minute (rpm) of hybridization oven; and 3)
batch design for labeling, hybridization and post-hybridization
processing. Details of the protocols used at each center are
provided in Supplementary Table S1.
Data analysis
Data from each center were provided in the form of CEL files.
To investigate variability among centers, we normalized and
analyzed data from each center separately.
Preprocessing to remove background signal and to normalize
across arrays was carried out using the Robust Multichip Average
method (RMA) [11] with software implemented in the R language
[19]. To identify differentially expressed genes we fit a general
linear model with terms for sex and strain to the data from each
gene. We computed the Fs statistic [20] using the MAANOVA
package and moderated F-statistic [21] from the LIMMA package,
both implemented in R. We also found that the two test statistics,
Fs and moderated F, yielded similar results as shown in Opgen-
Rhein et al. [22] and reported only the results from the Fs statistic
here. Nested permutation of sample labels was carried out to
obtain p-values for tests of sex and strain effects. Multiple test
adjustments were computed using the false discovery rate method
[12,13] as implemented in the q-value program [13]. To explore
the biological meaning of the differentially expressed gene lists, we
applied a hypergeometric test implemented in the GOstat R
package to identify over represented GO terms in the gene lists
[15].
Principal Components Analysis (PCA) is used for unsupervised
learning. PCA applies a singular value decomposition to the
covariance matrix of gene expression data to identify the
combination of conditions that explain the greatest variation in
the data. PCA was also used by Waring et al. [5] to illustrate the
reproducibility of microarray data across multiple centers. We
applied PCA separately to each center to see if the same
components of variation could be identified.
Accumulated data can be used to classify new samples [7–10].
We used non-negative matrix factorization (NMF) for classification
purpose. NMF partitions data V using two non-negative matrices
W and H, V,WH where W is a weight matrix that indicates how
much each gene contributes to each metagene pattern, and H
contains the expression profiles of the metagenes.
The metagene data can then be used to cluster genes or
samples. Among many implementation of NMF, we adopted the
metagene projection procedure as proposed by Tamayo et al. [9].
In the metagene projection method, a weight matrix W obtained
from a training set is used to compute the metagene profiles of a
target data set (H
*=W
21 V
*, where V
* is the target data).
Tamayo et al. [9] show that the projection can correctly cluster
samples from cross-platform or even cross-species studies. In our
application of this method, we chose one center as the training set,
computed the weight matrix, used it to compute a projection for
each of the other centers and clustered samples based on the
projected metagenes. We repeated this procedure using each
center as the training set, and compared the classification results.
To compare the performance of this approach, we applied
hierarchical clustering to the raw data. Euclidean distance is used
to measure the distance, and complete linkage method [23] is used
to cluster centers.
Supporting Information
Figure S1 Hierarchical clustering of H matrices from metagene
projection procedure using center 1, 2, or 5 as training sets.
Found at: doi:10.1371/journal.pone.0003724.s001 (1.69 MB TIF)
Table S1 Deatil sample processing information.
Found at: doi:10.1371/journal.pone.0003724.s002 (0.03 MB
XLS)
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